Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00928499 · ClinicalTrials.gov registry record · NA
Trial of Continuous Versus Cyclic Stimulation in Interstim Therapy
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00928499 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 32 participants.
The verdict
NCT00928499, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Sacral Nerve Stimulation (SNS) delivers non-painful, mild electrical pulses to the sacral nerves to modulate the reflexes that influence the bladder, sphincter, and pelvic floor to improve or restore normal voiding function. Sacral nerve stimulation is indicated for refractory voiding dysfunction including urinary urgency/frequency, urinary urge incontinence, and nonobstructive urinary retention. Since its introduction, SNS has undergone significant improvements in design and application so that implantation is now a minimally invasive procedure under local and intravenous (IV) sedation. However, despite the progress made in advancing this therapy to a minimally invasive procedure, there are neither data nor guidelines on ideal program settings. The purpose of this study is to evaluate the programming parameter of cyclic versus continuous stimulation on efficacy of the therapy. If the therapy is equally efficacious at both settings, the cyclic setting has the advantage of resulting in a longer battery life.
Interventions
- DEVICE Interstim (SNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00928499
The ClinicalTrials.gov registry entry for NCT00928499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interstim (SNS) is the first listed.
NCT00928499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00928499 about?
NCT00928499 is a clinical study titled "Trial of Continuous Versus Cyclic Stimulation in Interstim Therapy". Sacral Nerve Stimulation (SNS) delivers non-painful, mild electrical pulses to the sacral nerves to modulate the reflexes that influence the bladder, sphincter, and pelvic floor to improve or restore normal voiding function. Sacral nerve stimulation is indicated for refractory voiding dysfunction in...
What is the current status of trial NCT00928499?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2009-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00928499?
The interventions under investigation include: Interstim (SNS) (DEVICE).
Who is sponsoring clinical trial NCT00928499?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.